Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Goeddel David V
Relationship:   10% Owner
City:   So. San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   21,008,913    

Indirect Shares

   32,725,451      
Direct Value   $132,746,050    

Indirect Value

   $150,479,900      
Total Shares   53,734,364      
Total Value   $283,225,949      


Immune Design Corp. $0 Gritstone Oncology, Inc. $2,699,553 Rapt Therapeutics, Inc. $45,747,788 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $84,298,709 Nurix Therapeutics, Inc. $0 Immune Design Corp. $0 Gritstone Oncology, Inc. $2,699,553 Rapt Therapeutics, Inc. $45,747,788 Oric Pharmaceuticals, Inc. $0 Revolution Medicines, Inc. $84,298,709 Nurix Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    63   
    4    

     Stock price went up :
    24   
    1    
     Stock price went down :
    39   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -0.2%
 -73.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Immune Design Corp. IMDZ 10% Owner 2016-09-20 3,961,942 2014-07-29 0    Premium*  
            Gritstone Oncology, Inc. GRTS Managing Partner 2018-10-02 3,102,934 2018-10-02 0    Premium*  
            Ngm Biopharmaceuticals Inc NGM Director, 10% Owner 2024-04-05 0 2024-04-05 1,000    Premium*  
            Rapt Therapeutics, Inc. RAPT Managing Partner, 10% ... 2020-09-22 5,630,497 2019-11-04 195,401    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Managing Partner, 10% ... 2020-04-28 4,768,181 0    Premium*  
            Revolution Medicines, Inc. RVMD 10% Owner 2020-11-16 2,151,026 2020-11-16 3,799,202    Premium*  
            Nurix Therapeutics, Inc. NRIX 10% Owner 2021-05-05 1,394,333 2021-05-05 1,420,954    Premium*  
            Tenaya Therapeutics, Inc. TNYA 2021-08-03 0 2024-02-12 22,999,565    Premium*  
            Effector Therapeutics Ord Shs EFTR 10% Owner 0 2021-08-25 4,309,329    Premium*  
* Premium Members only  

Records found :    145         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-03 3 IO $0.00 $0 I/I 0 475,957 -
RAPT Rapt Therapeutics, Inc. Director   –       •       •   2019-10-30 3 IO $0.00 $0 I/I 0 50,000 -
ORIC Oric Pharmaceuticals, Inc... 10% Owner   –       –       •   2020-04-23 3 IO $0.00 $0 D/D 0 75,000 -
NRIX Nurix Therapeutics, Inc. 10% Owner   –       –       •   2020-07-23 3 IO $0.00 $0 D/D 0 83,333 -
EFTR Effector Therapeutics Ord... 10% Owner   –       –       •   2021-08-25 3 IO $0.00 $0 I/I 0 4,309,329 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2014-07-29 4 B $12.00 $4,788,192 D/D 399,016 3,161,942 2.45 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2014-07-29 4 A $0.00 $0 D/D 2,762,926 2,762,926 0 -
IMDZ Immune Design Corp. 10% Owner   –       –       •   2016-09-20 4 B $6.25 $5,000,000 D/D 800,000 3,961,942 2.45 -
GRTS Gritstone Oncology, Inc. Managing Partner   –       –      –    2018-10-02 4 A $0.00 $0 D/D 3,102,934 3,102,934 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 B $16.00 $30,000,000 I/I 1,875,000 15,634,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-04-08 4 A $0.00 $0 I/I 13,283,134 13,759,091 0 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-07 4 B $14.10 $803,700 I/I 57,000 15,691,091 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-10 4 B $13.85 $248,234 I/I 17,923 15,709,014 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-05-20 4 B $13.50 $675,000 I/I 50,000 15,759,014 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-04 4 B $13.39 $168,764 I/I 12,600 15,771,614 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-06 4 B $13.40 $168,884 I/I 12,600 15,784,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-07 4 B $13.66 $172,176 I/I 12,600 15,796,814 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-11 4 B $13.83 $150,718 I/I 10,900 15,807,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-12 4 B $14.00 $104,989 I/I 7,500 15,815,214 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-13 4 B $14.13 $162,508 I/I 11,500 15,826,714 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-14 4 B $14.00 $150,687 I/I 10,760 15,837,474 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-19 4 B $13.91 $211,674 I/I 15,214 15,852,688 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-20 4 B $13.86 $213,385 I/I 15,400 15,868,088 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-21 4 B $14.03 $52,789 I/I 3,763 15,871,851 2.25 -
NGM Ngm Biopharmaceuticals In... Director   –       •       •   2019-06-24 4 B $13.78 $168,650 I/I 12,240 15,884,091 2.25 -
  145  Records found
  1  2   3   4   5   6      
  Page 1 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us